About Algiax
Algiax is a company based in Erkrath (Germany) founded in 2011 by Guido Koopmans and Jurgen Schumacher.. Algiax has raised $11.6 million across 2 funding rounds from investors including KfW, OCCIDENT and High-Tech Gründerfonds. Algiax operates in a competitive market with competitors including Sana Biotechnology, Flexion Therapeutics, Semma Therapeutics, Adocia and Rezolute, among others.
- Headquarter Erkrath, Germany
- Founders Guido Koopmans, Jurgen Schumacher
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Algiax Pharmaceuticals Gmbh
-
Annual Revenue
$1.4 K (USD)0as on Dec 31, 2012
-
Net Profit
$-1.67 M (USD)0as on Dec 31, 2012
-
EBITDA
-
Total Equity Funding
$11.6 M (USD)
in 2 rounds
-
Latest Funding Round
$6.09 M (USD), Series A
Dec 11, 2019
-
Investors
KfW
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Algiax
Algiax has successfully raised a total of $11.6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.09 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $6.1M
-
First Round
First Round
(16 May 2012)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Series A - Algiax | Valuation | OCCIDENT – The Science Investor. |
|
| May, 2012 | Amount | Series A - Algiax | Valuation | KfW , HTGF |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Algiax
Algiax has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include KfW, OCCIDENT and High-Tech Gründerfonds. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are provided to deep-tech startups.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Founded Year | Domain | Location | |
|
Consumer and SME loans are provided across Germany.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Algiax
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Algiax
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Algiax Comparisons
Competitors of Algiax
Algiax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Flexion Therapeutics, Semma Therapeutics, Adocia and Rezolute, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for pain relief and inflammatory diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Algiax
Frequently Asked Questions about Algiax
When was Algiax founded?
Algiax was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Algiax located?
Algiax is headquartered in Erkrath, Germany. It is registered at Erkrath, North Rhine-westphalia, Germany.
Is Algiax a funded company?
Algiax is a funded company, having raised a total of $11.6M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5.51M, raised on May 16, 2012.
What is the annual revenue of Algiax?
Annual revenue of Algiax is $1.4K as on Dec 31, 2012.
What does Algiax do?
Algiax is dedicated to the discovery and development of innovative products in the field of nervous system disease or dysfunction with a strong focus on neuropathic pain. The company is financially stable having raised 4.3 million Euros in Series A financing from a consortium of private and state-backed investors. The pipeline includes AP-325 in clinical trial phase 1a for neuropathic pain and spinal cord injury, AP-61 in preclinical development for cognitive impairment and NCE for neuropathic pain and other CNS indications.
Who are the top competitors of Algiax?
Algiax's top competitors include Flexion Therapeutics, Sana Biotechnology and Semma Therapeutics.
Who are Algiax's investors?
Algiax has 3 investors. Key investors include KfW, OCCIDENT, and High-Tech Gründerfonds.